Top Losers Today - BSE Healthcare, Stock Market Stats - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Top Losers Today 
 : 
BSE Healthcare 

 

Here are the top top losers today from the BSE Healthcare index. To know more about the Index, please visit the BSE Healthcare Live Chart. Also read our detailed report on the pharmaceuticals sector.

FREE REPLAY: Discover What Richa Revealed in Her Smallcaps Summit

COMPANY PRICE (Rs) CHANGE (%) VOLUME ('000) DAY'S H/L (Rs) 52-WEEK H/L (Rs) GET MORE INFO
S&P BSE SENSEX 57,064.87 -0.34% - 58,183.77 /
56,867.51
62,245.43 /
44,118.10
 More Info 
NIFTY 50 16,983.20 -0.41% - 17,324.65 /
16,931.40
18,604.45 /
12,962.80
 More Info 
S&P BSE HEALTHCARE 25,501.80 0.11% - 25,699.96 /
25,404.09
26,979.05 /
19,863.84
 More Info 
SHALBY 137.30 -4.35% 19.32 147.00 /
135.55
214.00 /
94.05
 More Info 
ASTRAZENECA PHARMA 3,127.55 -4.01% 8.04 3,245.20 /
3,108.05
4,900.00 /
2,930.00
 More Info 
SHILPA MEDICARE 544.60 -3.64% 16.43 574.10 /
540.00
670.95 /
317.05
 More Info 
RPG LIFE SCIENCES 599.95 -3.63% 4.89 634.00 /
596.00
751.80 /
341.65
 More Info 
KOPRAN. 249.80 -3.50% 29.08 266.00 /
246.00
270.40 /
99.80
 More Info 
UNICHEM LAB 211.00 -3.30% 52.18 235.15 /
210.00
374.90 /
197.50
 More Info 
VALIANT ORGANICS 1,007.55 -3.13% 7.91 1,075.90 /
1,003.50
1,845.00 /
1,003.50
 More Info 
MOREPEN LABS 51.35 -2.65% 582.16 54.50 / 50.90 75.00 / 26.20  More Info 
FORTIS HEALTHCARE 280.90 -2.52% 114.58 292.95 /
279.45
304.00 /
141.15
 More Info 
DR. LAL PATHLABS 3,794.35 -2.37% 49.83 3,931.00 /
3,657.40
4,243.00 /
2,106.05
 More Info 
SASTASUNDAR VENTURES 475.75 -2.11% 11.12 506.00 /
462.20
575.00 /
97.00
 More Info 
IOL CHEMICALS & PHARM. 444.55 -2.09% 34.55 460.70 /
442.00
807.30 /
442.00
 More Info 
ERIS LIFESCIENCES 718.20 -2.01% 7.92 739.20 /
708.25
863.15 /
516.00
 More Info 
IND SWIFT LA 74.85 -1.84% 22.33 78.30 / 73.50 127.35 /
55.35
 More Info 
NGL FINE CHM 2,592.70 -1.58% 3.53 2,745.00 /
2,580.00
3,789.45 /
1,016.25
 More Info 
BAJAJ HEALTHCARE 351.70 -1.44% 13.09 366.55 /
344.00
511.90 /
208.00
 More Info 
PFIZER 5,194.40 -1.30% 2.45 5,301.85 /
5,109.70
6,164.80 /
4,200.00
 More Info 
INDOCO REMEDIES 389.30 -1.29% 13.64 407.35 /
384.05
529.70 /
251.90
 More Info 
ALBERT DAVID 575.55 -1.19% 2.52 594.15 /
574.95
673.00 /
371.45
 More Info 
BIOCON 360.30 -1.13% 198.43 370.60 /
357.90
487.70 /
314.90
 More Info 
SANOFI INDIA 7,947.45 -1.07% 0.49 8,131.00 /
7,900.00
9,300.00 /
7,427.75
 More Info 
STRIDES PHARMA SCIENCE 488.45 -1.07% 61.97 501.15 /
484.15
1,000.00 /
471.60
 More Info 
DIVIS LABORATORIES 4,880.70 -1.00% 20.59 4,950.00 /
4,841.00
5,425.00 /
3,154.50
 More Info 
BLISS GVS PHARMA 98.45 -0.91% 26.53 100.85 /
96.10
224.00 /
91.50
 More Info 
LUPIN 885.85 -0.83% 74.34 898.70 /
878.00
1,267.50 /
863.55
 More Info 

Date: November 30, 2021  (Close)     Only Buyers Only Buyers    Only Sellers Only Sellers   * Mutual Funds that hold this stock

What else is happening in the markets today? Dig in...


Today's Market

India's Fiscal Deficit, Anand Rathi Wealth IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a negative note yesterday. Benchmark indices edged lower as global cues turned bearish after US pharma.

Related Views on News

KOPRAN. 2020-21 Annual Report Analysis (Annual Result Update)

Nov 9, 2021 | Updated on Nov 9, 2021

Here's an analysis of the annual report of KOPRAN. for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of KOPRAN.. Also includes updates on the valuation of KOPRAN..

SHALBY 2020-21 Annual Report Analysis (Annual Result Update)

Nov 3, 2021 | Updated on Nov 3, 2021

Here's an analysis of the annual report of SHALBY for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SHALBY . Also includes updates on the valuation of SHALBY .

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 45.0% (Quarterly Result Update)

Aug 11, 2021 | Updated on Aug 11, 2021

For the quarter ended June 2021, ASTRAZENECA PHARMA has posted a net profit of Rs 102 m (down 45.0% YoY). Sales on the other hand came in at Rs 2 bn (down 9.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Nov 30, 2021 (Close)

COMPARE COMPANY

MARKET STATS